Adverse events · patients aged 0 to 18 years with a diagnosis of functional constipation
It is very uncertain whether high dose PEG changes adverse events compared with low dose PEG (very low certainty).
1 finding from 1 review
Frequency of defecation (mean number of bowel movements per week) · patients aged 0 to 18 years with a diagnosis of functional constipation
1 finding from 1 review
Frequency of defecation (mean number of bowel movements per week) · patients aged 0 to 18 years with a diagnosis of functional constipation
1 finding from 1 review
Frequency of defecation (mean number of bowel movements per week) · patients aged 0 to 18 years with a diagnosis of functional constipation
1 finding from 1 review
Successful disimpaction · patients aged 0 to 18 years with a diagnosis of functional constipation
Lactulose showed no clear difference in successful disimpaction compared with milk of magnesia (MOM) (low certainty).
1 finding from 1 review
Need for extra treatment · patients aged 0 to 18 years with a diagnosis of functional constipation
It is very uncertain whether lactulose changes need for additional therapies compared with milk of magnesia (MOM) (very low certainty).
1 finding from 1 review
Frequency of defecation (mean number of bowel movements per week) · patients aged 0 to 18 years with a diagnosis of functional constipation
1 finding from 1 review
Frequency of defecation (mean number of bowel movements per week) · patients aged 0 to 18 years with a diagnosis of functional constipation
1 finding from 1 review
Need for extra treatment · patients aged 0 to 18 years with a diagnosis of functional constipation
PEG may leads to lower need for additional therapies compared with lactulose (low certainty).
1 finding from 1 review
Successful disimpaction · patients aged 0 to 18 years with a diagnosis of functional constipation
PEG may leads to lower successful disimpaction compared with lactulose (low certainty).
1 finding from 1 review
Adverse events · patients aged 0 to 18 years with a diagnosis of functional constipation
PEG showed no clear difference in adverse events compared with lactulose (moderate certainty).
1 finding from 1 review
Serious adverse events · patients aged 0 to 18 years with a diagnosis of functional constipation
PEG showed no clear difference in serious adverse events compared with lactulose (low certainty).
1 finding from 1 review
Frequency of defecation (mean number of bowel movements per week) · patients aged 0 to 18 years with a diagnosis of functional constipation
1 finding from 1 review
Successful disimpaction · patients aged 0 to 18 years with a diagnosis of functional constipation
PEG showed no clear difference in successful disimpaction compared with milk of magnesia (MOM) (low certainty).
1 finding from 1 review